Subsequent to quarter-end, the Company completes an
Summary Consolidated Financial Highlights
Results of Operations — Three Months Ended
- Gross Revenue (a Non-GAAP measure) decreased 73.2% to
$2.6 million for the three months endedJune 30, 2026 , compared to$9.5 million for the comparable prior-year period. - Net Revenue decreased 73.1% to
$2.5 million for the three months endedJune 30, 2026 , compared to$9.2 million for the comparable prior-year period. - Net cash used in operating activities was
$2.8 million for the three months endedJune 30, 2026 , compared to net cash used in operating activities of$0.3 million for the comparable prior-year period. - Loss from operations was
$2.1 million for the three months endedJune 30, 2026 , compared with income from operations of$0.4 million for the comparable prior-year period.
Results of Operations — Six Months Ended
- Gross Revenue (a Non-GAAP measure) decreased 68.8% to
$6.0 million for the six months endedJune 30, 2026 , compared to$19.4 million for the comparable prior-year period. - Net Revenue decreased 68.3% to
$5.8 million for the six months endedJune 30, 2026 , compared to$18.4 million for the comparable prior-year period. - Net cash used in operating activities was
$5.6 million for the six months endedJune 30, 2026 , compared to net cash used in operating activities of$3.7 million for the comparable prior-year period. - Loss from operations was
$4.3 million for the six months endedJune 30, 2026 , compared with income from operations of$0.6 million for the comparable prior-year period.
Balance Sheet Data —
- Cash, cash equivalents and digital assets decreased 61.1% to
$6.0 million atJune 30, 2026 , a decrease of$9.4 million from$15.5 million atDecember 31, 2025 . The decrease was primarily attributable to net cash used in operations of$5.6 million , a$2.0 million equity investment in an early-stage company developing next-generation nuclear power and infrastructure technology, and a$1.7 million unrealized loss on the Company's Bitcoin holdings. - Total assets decreased
$8.0 million , or 37.3%, to$13.5 million . Total liabilities decreased$0.7 million , or 5.4%, to$11.9 million . The Company's current ratio was 0.84 as ofJune 30, 2026 . - Working capital decreased 112.8% at
June 30, 2026 , a decline of$7.8 million fromDecember 31, 2025 , excluding$4.0 million of liquid digital assets held at quarter-end. - Outstanding debt increased
$0.2 million to$3.7 million atJune 30, 2026 , up from$3.5 million atDecember 31, 2025 . - Total stockholders' equity was
$1.6 million atJune 30, 2026 , a decrease of$7.3 million , or 82.2%, from$8.9 million atDecember 31, 2025 .
Direct-to-Consumer Marketing Platform —
During the quarter, the Company continued to implement a shift in its strategic plan to evolve
Subsequent to quarter-end, in late
Discontinued Blockchain Technology and Crypto Mining Segment
In early
Health, Beauty, and Wellness Products
The Health, Beauty and Wellness Products segment generated net revenue of
Subsequent to quarter-end, the Company expanded Renu's marketing and business-development activity and invested in manufacturing equipment, production technology, and key personnel to rebuild volume and support both third-party manufacturing and the Company's internal wellness products. Management continues to evaluate Renu against revenue, customer economics, operating costs, and capital requirements.
MyLife Wellness
MyLife Wellness (“MLW”), the Company's consumer health and wellness brand, connects Renu's product-development and manufacturing capabilities with
Subsequent to quarter-end, the Company launched a multi-channel direct-to-consumer initiative supporting MLW alongside the existing distributor network; because it launched after quarter-end, it did not materially contribute to second-quarter results.
Financial Services Initiatives
During the second quarter, the Company continued the pre-commercial development of
The Company had previously targeted commercialization for late second quarter or early third quarter 2026. During the quarter, management reviewed Opencash’s technology, planned capabilities and commercialization strategy, and determined to extend the pre-commercialization phase rather than launch the platform under its initial configuration. The Company elected to commit additional resources to advance platform functionality, operational readiness and the customer offering prior to broader commercialization.
Planned capabilities include trading in equities, exchange-traded funds (“ETFs”), equity options, and mutual funds, subject to applicable regulatory requirements, third-party capabilities, and system readiness, together with enhanced market data, investor tools, technology-enabled personalization, and engagement and rewards functionality. The Company plans to offer Opencash, a mobile application for self-directed investors, and OpencashPro, a web-based platform for active and more experienced traders.
The Company is currently targeting initial commercial operations by the end of the second quarter of 2027, followed by a phased expansion during the remainder of 2027 and into 2028; however, no definitive commercialization date has been established. The revised timeline reflects management’s decision to further advance the platform’s functionality and commercial readiness prior to broader market introduction. As of
During the fourth quarter of 2025 and first quarter of 2026, the Company invested an aggregate of
Subsequent to quarter-end, in
Because the sale closed subsequent to
Management Commentary
“The second-quarter results reflect a significant deterioration in operating performance, driven principally by contraction in our European network, lower health, beauty and wellness revenue, and continued investment in businesses that are not yet self-supporting. The results reinforce the need for greater focus, more disciplined capital allocation, and stronger economic performance across the portfolio.
“Our response has been to simplify the portfolio and clarify the role of each operating business.
“We applied the same discipline to Opencash. Because the technology, compliance and operational work required for commercialization was incomplete, we extended the pre-commercialization phase rather than launch prematurely. No revised commercialization date has been established.
“Subsequent to quarter-end, we completed the sale of a portion of our private nuclear-technology investment for approximately
About
About Opencash Securities LLC
Brokerage services are provided by Opencash Securities LLC, a member of FINRA and SIPC. Options involve risk and are not suitable for all investors. Please review Characteristics and Risks of Standardized Options prior to engaging in options trading. Opencash Securities LLC does not provide investment advice. Please consult with investment, tax, or legal professionals before making any investment decisions. All investments involve risk, including the possible loss of capital. Check the background of this investment professional on BrokerCheck. Opencash Securities LLC is a wholly-owned subsidiary of Investview, Inc.
Investor Relations
Contact: Ralph R. Valvano
Phone Number: 732.889.4300
Email: pr@investview.com
Reconciliation of Gross Revenue to Net Revenue
(unaudited)
As used in this report, Gross Revenue is not a measure of financial performance under United States Generally Accepted Accounting Principles (“GAAP”). Gross Revenue is presented as it is used by management to understand total revenue before certain items such as refunds, incentives, credits, chargebacks, and amounts paid to third-party providers. This non-GAAP measure supplements the Company's GAAP financial information. A reconciliation between Gross Revenue (non-GAAP) and Net Revenue is presented below.
Six Months Ended June 30, 2026
| Membership Revenue | Health, Beauty, & Wellness | Coffee Sales | Other Revenue | Total | ||||||||||
| Gross billings/receipts | $ | 5,037,436 | $ | 513,037 | $ | 482,812 | $ | 12,179 | $ | 6,045,464 | ||||
| Refunds, incentives, credits, & chargebacks | $ | (197,042 | ) | $ | (1,713 | ) | $ | (30,306 | ) | — | $ | (229,061 | ) | |
| Net revenue | $ | 4,840,394 | $ | 511,324 | $ | 452,506 | $ | 12,179 | $ | 5,816,403 | ||||
Six Months Ended
| Membership Revenue | Health, Beauty, & Wellness | Other Revenue | Total | ||||||||
| Gross billings/receipts | $ | 17,639,140 | $ | 1,680,190 | $ | 45,651 | $ | 19,364,981 | |||
| Refunds, incentives, credits, & chargebacks | $ | (1,003,015 | ) | $ | (171 | ) | — | $ | (1,003,186 | ) | |
| Net revenue | $ | 16,636,125 | $ | 1,680,019 | $ | 45,651 | $ | 18,361,795 | |||
Three Months Ended
| Membership Revenue | Health, Beauty, & Wellness | Coffee Sales | Other Revenue | Total | ||||||||||
| Gross billings/receipts | $ | 2,183,419 | $ | 242,645 | $ | 132,727 | $ | 2,306 | $ | 2,561,097 | ||||
| Refunds, incentives, credits, & chargebacks | $ | (86,044 | ) | $ | (93 | ) | $ | (681 | ) | — | $ | (86,818 | ) | |
| Net revenue | $ | 2,097,375 | $ | 242,552 | $ | 132,046 | $ | 2,306 | $ | 2,474,279 | ||||
Three Months Ended
| Membership Revenue | Health, Beauty, & Wellness | Other Revenue | Total | ||||||||
| Gross billings/receipts | $ | 8,199,283 | $ | 1,311,747 | $ | 38,307 | $ | 9,549,337 | |||
| Refunds, incentives, credits, & chargebacks | $ | (354,601 | ) | $ | (49 | ) | — | $ | (354,650 | ) | |
| Net revenue | $ | 7,844,682 | $ | 1,311,698 | $ | 38,307 | $ | 9,194,687 | |||
Source: 